Accessibility Menu
RenovoRx logo

RenovoRx

(NASDAQ) RNXT

Current Price$0.93
Market Cap$41.45M
Since IPO (2021)-87%
5 YearN/A
1 Year-29%
1 Month+1%

RenovoRx Financials at a Glance

Market Cap

$41.45M

Revenue (TTM)

$1.49M

Net Income (TTM)

-$12.27M

EPS (TTM)

-$0.33

P/E Ratio

-2.78

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.93

Volume

1,206

Open

$0.93

Previous Close

$0.93

Daily Range

$0.92 - $0.93

52-Week Range

$0.70 - $1.45

Estimated Earnings Date

Aug 13, 2026

RNXT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RenovoRx

Industry

Biotechnology

Employees

17

CEO

Shaun R. Bagai

Headquarters

Mountain View, CA 94022, US

RNXT Financials

Key Financial Metrics (TTM)

Gross Margin

78.71%

Operating Margin

-864.34%

Net Income Margin

-823.98%

Return on Equity

-138.61%

Return on Capital

-222.04%

Return on Assets

-87.86%

Earnings Yield

-35.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.45M

Shares Outstanding

45.05M

Volume

1.21K

Avg. Volume

292.72K

Financials (TTM)

Gross Profit

$1.17M

Operating Income

-$12.87M

EBITDA

-$12.27M

Operating Cash Flow

-$11.30M

Capital Expenditure

$0.00

Free Cash Flow

-$11.30M

Cash & ST Invst.

$12.36M

Total Debt

$186.00K

RenovoRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$563.00K

+185.8%

Gross Profit

$479.00K

+365.0%

Gross Margin

85.08%

N/A

Market Cap

$41.45M

N/A

Market Cap/Employee

$4.15M

N/A

Employees

10

N/A

Net Income

-$3.52M

-45.5%

EBITDA

-$3.52M

-45.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$12.36M

-15.2%

Total Debt

$186.00K

-34.3%

Accounts Receivable

$280.00K

+15.7%

Inventory

$379.00K

N/A

Long Term Debt

$78.00K

-58.1%

Short Term Debt

$108.00K

+11.3%

Return on Assets

-87.86%

N/A

Return on Invested Capital

-1.07%

N/A

Free Cash Flow

-$3.71M

-9.6%

Operating Cash Flow

-$3.71M

-9.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ELUTElutia Inc
$0.93-1.28%
ANVSAnnovis Bio, Inc.
$1.93+0.52%
LTRNLantern Pharma Inc.
$3.97-1.24%
PYPDPolyPid Ltd.
$5.02-0.59%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About RNXT

What is the current price of RenovoRx?

RenovoRx is trading at $0.93 per share.

What is the 52-week range for RenovoRx?

Over the past 52 weeks, RenovoRx has traded between $0.70 and $1.45.

How much debt does RenovoRx have?

As of the most recent reporting period, RenovoRx reported total debt of $186.00K.

How much cash does RenovoRx have on hand?

RenovoRx reported $12.36M in cash and cash equivalents in its most recent financial results.

What is RenovoRx’s dividend yield?

RenovoRx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.